Effects of sex and hormonal status on astrocytic basic fibroblast growth factor-2 and tyrosine hydroxylase immunoreactivity after medial forebrain bundle 6-hydroxydopamine lesions of the midbrain dopamine neurons

Neuroscience

Volumn 118, Issue 2, 2003, Pages 463-476

  Moroz, I A ^a   Rajabi, H ^a   Rodaros, D ^a   Stewart, J ^a  

^a and Applied Physiology   (Canada)

Author keywords

6 OHDA; Estrogen; FGF 2; Midbrain dopaminergic neurons; Substantia nigra; Testosterone; VTA

Indexed keywords

ESTROGEN; FIBROBLAST GROWTH FACTOR 2; NEUROTOXIN; OXIDOPAMINE; SEX HORMONE; TESTOSTERONE; TYROSINE 3 MONOOXYGENASE;

ADULTHOOD; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CONTROLLED STUDY; CORRELATION ANALYSIS; DOPAMINERGIC NERVE CELL; FEMALE; IMMUNOREACTIVITY; MALE; MEDIAL FOREBRAIN BUNDLE; MESENCEPHALON; NERVE INJURY; NEWBORN; NEWBORN PERIOD; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SEX DIFFERENCE;

EID: 0037426580     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(02)00974-0     Document Type: Article

References (72)

1. Altar C.A., Marien M.R., Marshall J.F. Time course of adaptations in dopamine biosynthesis, metabolism, and release following nigrostriatal lesions implications for behavioral recovery from brain injury . J Neurochem. 48:1987;390-399.
2. + evaluations using in vitro and in vivo techniques . Brain Res. 872:2000;160-171.
3. Becker J.B. Estrogen rapidly potentiates amphetamine-induced striatal dopamine release and rotational behavior during microdialysis. Neurosci Lett. 118:1990;169-171.
4. Becker J.B., Ramirez V.D. Sex differences in the amphetamine stimulated release of catecholamines from rat striatal tissue in vitro. Brain Res. 204:1981;361-373.
5. Becker J.B., Robinson T.E., Lorenz K. Sex differences and estrous cycle variations in amphetamine-elicited rotational behavior. Eur J Pharmacol. 80:1982;65-72.
6. Becker J.B., Rudick C.N. Rapid effects of estrogen or progesterone on the amphetamine-induced increase in striatal dopamine are enhanced by estrogen priming a microdialysis study . Pharmacol Biochem Behav. 64:1999;53-57.
7. Brooks W.J., Jarvis M.F., Wagner G.C. Influence of sex, age, and strain on MPTP-induced neurotoxicity. Res Commun Subst Abuse. 10:1989;181-184.
8. Cador M., Bjijou Y., Cailhol S., Stinus L. D-amphetamine induced behavioral sensitization implication of a glutamatergic medial prefrontal cortex-ventral tegmental area innervation . Neuroscience. 94:1999;705-721.
9. Callier S., Morissette M., Grandbois M., Di Paolo T. Stereospecific prevention by 17β-estradiol of MPTP-induced dopamine depletion in mice. Synapse. 37:2000;251.
10. Camp D.M., Robinson T.E. Susceptibility to sensitization I . Sex differences in the enduring effects of chronic d-amphetamine treatment on locomotion, stereotyped behavior and brain monoamines. Behav Brain Res. 30:1988;55-68.
11. Carman L.S., Gage F., Shults C.W. Partial lesions of the substantia nigra relation between extent of lesion and rotational behavior . Brain Res. 533:1991;275-283.
12. Castaneda E., Whishaw I.Q., Robinson T.E. Changes in striatal dopamine neurotransmission assessed with microdialysis following recovery from a bilateral 6-OHDA lesion variation as a function of lesion size . J Neurosci. 10:1990;1847-1854.
13. Chadi G., Cao Y., Pettersson R.F., Fuxe K. Temporal and spatial increase of astroglial basic fibroblast growth factor synthesis after 6-hydroxydopamine-induced degeneration of the nigrostriatal dopamine neurons. Neuroscience. 61:1994;891-910.
14. Costall B., Marsden C.D., Naylor R.J., Pycock C.J. The relationship between striatal and mesolimbic dopamine dysfunction and the nature of circling responses following 6-hydroxydopamine and electrolytic lesions of the ascending dopamine systems of rat brain. Brain Res. 118:1976;87-113.
15. Di Paolo T., Rouillard C., Bedard P. 17β-Estradiol at a physiological dose acutely increases dopamine turnover in rat brain. Eur J Pharmacol. 117:1985;197-203.
16. Disshon K.A., Boja J.W., Dluzen D.E. Inhibition of striatal dopamine transporter activity by 17β-estradiol. Eur J Pharmacol. 345:1998;207-211.
17. + in female, but not male rats. Brain Res. 868:2000;95-104.
18. Dluzen D.E. Estrogen decreases corpus striatal neurotoxicity in response to 6-hydroxydopamine. Brain Res. 767:1997;340-344.
19. Dluzen D.E., McDermott J.L., Liu B. Estrogen alters MPTP-induced neurotoxicity in female mice effects on striatal dopamine concentrations and release . J Neurochem. 66:1996;658-666.
20. Dluzen D.E., McDermott J.L., Liu B. Estrogen as a neuroprotectant against MPTP-induced neurotoxicity in C57/Bl mice. Neurotoxicol Teratol. 18:1996;603-606.
21. Doherty P. Neuroprotective effects of estrogen upon the nigrostriatal dopaminergic system. J Neurocytol. 29:2000;387-399.
22. Eclancher F., Kehrli P., Labourdette G., Sensenbrenner M. Basic fibroblast growth factor (bFGF) injection activated the glial reaction in the injured adult rat brain. Brain Res. 737:1996;201-214.
23. Emmi A., Rajabi H., Stewart J. Behavioral and neurochemical recovery from partial 6-hydroxydopamine lesions of the substantia nigra is blocked by daily treatment with glutamate receptor antagonists MK-801 and CPP. J Neurosci. 16:1996;5216-5224.
24. Emmi A., Rajabi H., Stewart J. Behavioral and neurochemical recovery from partial 6-hydroxydopamine lesions of the substantia nigra is blocked by daily treatment with D1/D5, but not D2, dopamine receptor antagonists. J Neurosci. 17:1997;. 3840-3384.
25. Engele J., Bohn M.C. The neurotrophic effects of fibroblast growth factors on dopaminergic neurons in vitro are mediated by mesencephali glia. J Neurosci. 11:1991;3070-3078.
26. Flores C., Rodaros D., Stewart J. Long-lasting induction of astrocytic basic fibroblast growth factor by repeated injections of amphetamine blockade by concurrent treatment with a glutamate antagonist . J Neurosci. 18:1998;9547-9555.
27. Flores C., Salmaso N., Cain S., Rodaros D., Stewart J. Ovariectomy of adult rats leads to increased expression of astrocytic basic fibroblast growth factor in the ventral tegmental area and in dopaminergic projection regions of the entorhinal and prefrontal cortex. J Neurosci. 19:1999;8665-8673.
28. Forgie M.L., Stewart J. Sex differences in amphetamine-induced locomotor activity in adult rats role of testosterone exposure in the neonatal period . Pharmacol Biochem Behav. 46:1993;637-645.
29. Forgie M.L., Stewart J. Effect of prepubertal ovariectomy on amphetamine-induced locomotor activity in adult female rats. Horm Behav. 28:1994;241-260.
30. Freyaldenhoven T.E., Cadet J.L., Ali S.F. The dopamine-depleting effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in CD-1 mice are gender-dependent. Brain Res. 735:1996;232-238.
31. Gainetdinov R.R., Fumagalli F., Jones S.R., Caron M.G. Dopamine transporter is required for in vivo MPTP neurotoxicity evidence from mice lacking the transporter . J Neurochem. 69:1997;1322-1325.
32. Giulian D., Vaca K., Corpuz M. Brain glia release factors with opposing actions upon neuronal survival. J Neurosci. 13:1993;29-37.
33. Gordon M.N., Schreier W.A., Ou X., Holcomb L.A., Morgan D.G. Exaggerated astrocyte reactivity after nigrostriatal deafferentiation in the aged rat. J Comp Neurol. 388:1997;106-119.
34. Grandbois M., Morissette M., Callier S., Di Paolo T. Ovarian steroid and raloxifene prevent MPTP-induced dopamine depletion in mice. Neuroreport. 11:2000;343-346.
35. Guillamon A., De Blas M.R., Segovia S. Effects of sex steroids on the development of the locus coeruleus in the rat. Dev Res. 40:1998;306-310.
36. Hou J.-G.G., Cohen G., Mytilineou C. Basic fibroblast growth factor stimulation of glial cells protects dopamine neurons from 6-hydroxydopamine toxicity involvement of the glutathione system . J Neurochem. 69:1997;76-83.
37. Ichitani Y., Okamura H., Nakahara D., Nagatsu I., Ibata Y. Biochemical and immunocytochemical changes induced by intrastriatal 6-hydroxydopamine injection in the rat nigrostriatal dopamine neuron system evidence for cell death in the substantia nigra . Exp Neurol. 130:1994;269-278.
38. Juraska J.M., Kopcik J.R., Washburne D.L., Perry D.L. Neonatal castration of male rats affects the dendritic response to differential environments in granule neurons of the hippocampal dentate gyrus. Psychobiology. 16:1988;406-410.
39. Kalivas P.W., Stewart J. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res Rev. 16:1991;223-244.
40. Karler R., Calder L.D., Chaudhry I.A., Turkanis S.A. Blockade of "reverse tolerance" to cocaine and amphetamine by MK-801. Life Sci. 45:1989;599-606.
41. Kim J.-H., Vezina P. Metabotropic glutamate receptors are necessary for sensitization by amphetamine. Neuroreport. 9:1998;403-406.
42. Kirik D., Rosenblad C., Bjorklund A. Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat. Exp Neurol. 152:1998;259-277.
43. Lee C.S., Sauer H., Bjorklund A. Dopaminergic neuronal degeneration and motor impairments following axon terminal lesion by intrastriatal 6-hydroxydopamine in the rat. Neuroscience. 72:1996;641-653.
44. Luque J.M., De Blas M.R., Segovia S., Guillamon A. Sexual dimorphism of the dopamine-beta-hydroxylase-immunoreactive neurons in the rat locus coeruleus. Dev Brain Res. 67:1992;211-215.
45. Marshall J.F., Drew M.C., Neve K.A. Recovery of function after mesotelencephalic dopaminergic injury in senescence. Brain Res. 259:1983;249-260.
46. McDermott J.L., Liu B., Dluzen D.E. Sex differences and effects of estrogen on dopamine and DOPAC release from the striatum of male and female CD-1 mice. Exp Neurol. 125:1994;306-311.
47. Miller D.B., Ali S.F., O'callaghan J.P., Laws S.C. The impact of gender and estrogen on striatal dopaminergic neurotoxicity. Ann NY Acad Sci. 844:1998;153-165.
48. Miller G.W., Gainetdinov R.R., Levey A.I., Caron M.G. Dopamine transporters and neuronal injury. Trends Pharmacol Sci. 20:1999;424-429.
49. Milner T.A., Loy R. Hormonal regulation of axonal sprouting in the hippocampus. Brain Res. 243:1982;180-185.
50. Mishra R.K., Marshall A.M., Varmuza S.L. Supersensitivity in rat caudate nucleus effects of 6-hydroxydopamine on the time course of dopamine receptor and cyclic AMP changes . Brain Res. 200:1980;47-57.
51. Neve K.A., Kozlowski M.R., Marshall J.F. Plasticity of neostriatal dopamine receptors after nigrostriatal injury relationship to recovery of sensorimotor functions and behavioral supersensitivity . Brain Res. 244:1982;33-44.
52. Nisenbaum L.K., Kitai S.T., Crowley W.R., Gerfen C.R. Temporal dissociation between changes in striatal enkephalin and substance P messenger RNAs following striatal dopamine depletion. Neuroscience. 60:1994;927-937.
53. Nomura T., Yabe T., Rosenthal E.S., Krzan M., Schwartz J.P. PSA-NCAM distinguishes reactive astrocytes in 6-OHDA-lesioned substantia nigra from those in the striatal terminal fields. J Neurosci Res. 61:2000;588-596.
54. Palkovits M, Brownstein MJ (1988) Maps and guide to microdissection of the rat brain. New York: Elsevier.
55. Pasqualini C., Olivier V., Guibert B., Frain O., Leviel V. Acute stimulatory effect of estradiol on striatal dopamine synthesis. J Neurochem. 65:1995;1651-1657.
56. Paxinos G, Watson C (1997) The rat brain in stereotaxic coordinates. New York: Academic.
57. Przedborski S., Levivier M., Jiang H., Ferreira M., Jackson-Lewis V., Donaldson D., Togasaki D.M. Dose-dependent lesions of the dopaminergic nigrostriatal pathway induced by intrastriatal injection of 6-hydroxydopamine. Neuroscience. 67:1995;631-647.
58. Robinson T.E., Becker J.B. Enduring changes in brain and behavior produced by chronic amphetamine administration a review and evaluation of animal models of amphetamine psychosis . Brain Res Rev. 396:1986;157-198.
59. Robinson T.E., Mocsary Z., Camp D.M., Whishaw I.Q. Time course of recovery of extracellular dopamine following partial damage to the nigrostriatal dopamine system. J Neurosci. 14:1994;2687-2696.
60. Robinson T.E., Whishaw I.Q. Normalization of extracellular dopamine in striatum following recovery from a partial unilateral 6-OHDA lesion of the substantia nigra a microdialysis study in freely moving rats . Brain Res. 450:1988;209-224.
61. Rodriguez R.W.P., Gomide V.C., Chadi G. Astroglial and microglial reaction after a partial nigrostriatal degeneration induced by the striatal injection of different doses of 6-hydroxydopamine. Int J Neurosci. 109:2001;91-126.
62. Sauer H., Oertel W.H. Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine a combined retrograde tracing and immunocytochemical study in the rat . Neuroscience. 59:1994;401-415.
63. Sheng J.G., Shirabe S., Nishiyama N., Schwartz J.P. Alterations in striatal glial fibrillary acidic protein expression in response to 6-hydroxydopamine-induced denervation. Exp Brain Res. 95:1993;450-456.
64. Snyder G.L., Keller R.W., Zigmond M. Dopamine efflux from striatal slices after intracerebral 6-hydroxydopamine evidence for compensatory hyperactivity of residual terminals . J Pharmacol Exp Ther. 253:1990;867-876.
65. Stewart J., Druhan J.P. Development of both conditioning and sensitization of the behavioral activating effects of amphetamine is blocked by the non-competitive NMDA receptor antagonist, MK-801. Psychopharmacology. 110:1993;125-132.
66. Stewart J., Kolb B. Dendritic branching in cortical pyramidal cells in response to ovariectomy in adult female rats suppression by neonatal exposure to testosterone . Brain Res. 654:1994;149-154.
67. Stromberg I., Bjorklund H., Dahl D., Jonsson G., Sundstrom E., Olson L. Astrocyte responses to dopaminergic denervations by 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine as evidenced by glial fibrillary acidic protein immunohistochemistry. Brain Res Bull. 17:1986;225-236.
68. Thompson T.L. Attenuation of dopamine uptake in vivo following priming with estradiol benzoate. Brain Res. 834:1999;164-167.
69. Tillerson J.L., Cohen A.D., Philhower J., Miller G.W., Zigmond M.J.S.T. Forced limb-use effects on the behavioral and neurochemical effects of 6-hydroxydopamine. J Neurosci. 21:2001;4427-4435.
70. Wagner G.C., Tekiran T.L., Cheo C.T. Sexual differences in sensitivity to methamphetamine toxicity. J Neural Transm. 93:1993;67-70.
71. Wolf M., Jeziorski M. Coadministration of MK-801 with amphetamine, cocaine or morphine prevents rather than transiently masks the development of behavioral sensitization. Brain Res. 613:1993;291-294.
72. Yu Y.-L., Wagner G.C. Influence of gonadal steroid hormones on sexual differences in sensitivity to methamphetamine-induced neurotoxicity. J Neural Transm. 8:1994;215-221.